Of course, the same platform can be further exploited to identify novel pathways affecting E2:ERα signaling to BC cell proliferation by applying siRNA or CRISPR/CAS9 libraries directed against the specific protein of choice, thus providing the opportunity to pinpoint novel druggable proteins and/or cellular pathways potentially usable in BC treatments. Here, ESR1 is linked to breast cancer.